Role of MAPKs in platinum-induced neuronal apoptosis

Arianna Scuteri1, Alessia Galimberti, Daniele Maggioni

  • 1Dipartimento di Neuroscienze e Tecnologie Biomediche, Università degli Studi di Milano-Bicocca, Monza, Italy. arianna.scuteri@unimib.it

Neurotoxicology
|May 12, 2009
PubMed

Insights

Platinum chemotherapy drugs cause nerve damage by inducing apoptosis in sensory neurons. Specific mitogen-activated protein kinases (MAPKs) like p38 and ERK1/2 mediate this damage, while JNK/Sapk plays a protective role.

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Platinum derivatives (oxaliplatin, cisplatin) are vital in solid cancer therapy.
  • Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting side effect.
  • The precise mechanisms of platinum-induced neuronal apoptosis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of mitogen-activated protein kinases (MAPKs) in platinum-induced apoptosis of dorsal root ganglion (DRG) neurons.
  • To elucidate the specific signaling pathways involved in chemotherapy-induced peripheral neuropathy.

Main Methods:

  • DRG neurons from E15 rat embryos were exposed to toxic doses of oxaliplatin or cisplatin.
  • Western blotting and specific MAPK inhibitors were used to analyze MAPK activation and function.
  • Bcl-2 family protein modulation was assessed in relation to apoptosis.

Main Results:

  • Both oxaliplatin and cisplatin induced dose-dependent neuronal apoptosis, modulated by Bcl-2 family proteins.
  • Platinum agents activated p38 and early ERK1/2, while reducing JNK/Sapk.
  • Inhibition studies revealed p38 and ERK1/2 activation mediate apoptosis, whereas JNK/Sapk exhibits neuroprotection.

Conclusions:

  • MAPK signaling pathways differentially regulate platinum-induced DRG neuron apoptosis.
  • Early p38 and ERK1/2 activation are key mediators of CIPN.
  • JNK/Sapk signaling may represent a potential therapeutic target for mitigating platinum neurotoxicity.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...